Corporate Banner
Satellite Banner
Technology Networks Header
Monday, September 01, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Protect Personnel from Chemical Vapors
Saturday, August 30, 2014
New Vent-Box ductless filtration system from Air Science.

Shimadzu Announces New i-Series Integrated Liquid Chromatography Systems
Thursday, August 21, 2014
Innovative, intuitive and intelligent functionality advances HPLC for labs of the future.

Reproducible Evaporation of Environmental Samples
Thursday, August 14, 2014
EZ-2 ENVI from Genevac give excellent recovery and reproducibility.

New Phenomenex GC Column Set for Chlorinated Pesticides
Friday, July 25, 2014
The Zebron ZB-CLPesticides GC column runs seven EPA methods.

Vanquish UHPLC sees Thermo Fisher Scientific Reimagine UHPLC
Tuesday, July 15, 2014
Thermo Fisher Scientific has unveiled a new high performance liquid chromatography system designed from the ground up to provide new levels of performance, productivity and usability when used as a standalone system or with the latest mass spectrometers.

Automated Sample Preparation for the Analysis of Dioxins and PCBs
Tuesday, July 15, 2014
Dioxin system DEXTech™ to be presented by LCTech at Dioxin 2014 in Madrid.

Determination of PAHs in Environmental Waters
Saturday, June 21, 2014
A high-performance liquid chromatography method to determine polycyclic aromatic hydrocarbons in tap water.

Agilents' New 6495 LC/MS Triple Quadrupole System
Tuesday, June 17, 2014
Provides confident quantitation and confirmation for most demanding applications.

New AB SCIEX Triple Quad™ 3500 System Redefines Simplified Mass Spec
Tuesday, June 17, 2014
New engineering and software deliver significant increase in quantitation and analysis power.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 362
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv